Blog

NRC Next 31/08: Steven vd Vijver AMC/AIGHD, Obesitas and cardiovascular disease in the slums of Nairobi Read the article (Dutch only)..> ...

New publication of the most recent paper from INTERACT project H (Read more on Interact..>)  Rulisa S, Kaligirwa N, Agaba S, Karema C, Mens PF and De Vries PJ. Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda. Malaria Journal 2012, 11:225 (6 July 2012). To view the...

Another publication of HIV-NAT (HIV Netherlands Australia Thailand Research Collaboration) has been accepted Prevalence of anemia and underlying iron status in naïve antiretroviral therapy HIV-infected children with moderate immune suppression Pope Kosalaraksa, Torsak Bunupuradah, Vonthanak Saphonn, Surapon Wiangnon, Rawiwan Hansudewechakul, Ung Vibol, Suparat Kanchanawanit, Chaiwat Ngampiyaskul,...

Two more papers of HIV-NAT (HIV Netherlands Australia Thailand Research Collaboration) have been published Rongkavilit C, Naar-King S, Koken JA, Bunupuradah T, Chen X, Saengcharnchai P, Panthong A, Parsons JT. A Feasibility Study of Motivational Interviewing for Health Risk Behaviors Among Thai Youth Living With HIV. J Assoc...

Another paper of HIV-NAT (HIV Netherlands Australia Thailand Research Collaboration) has been published Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavej S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Kerr SJ, Sophonphan J, Bhakeecheep S, Hirschel B, Ruxrungtham K; the HIV STAR Study Group....

The US Food and Drug Administration (FDA) announced the approval of the antiretroviral drug TDF/FTC (brand name Truvada) for use as pre-exposure prophylaxis (PrEP) among sexually active adult men and women in the US. This approval paves the way for daily oral PrEP using TDF/FTC...